반응식
[N+:1]([C:4]1[CH:13]=[CH:12][CH:11]=[C:10]2[C:5]=1[CH:6]=[CH:7][C:8](Cl)=[N:9]2)([O-])=O.[NH2:15][C:16]1[C:24]2[O:23][C:22]([CH3:26])([CH3:25])[CH2:21][C:20]=2[CH:19]=[CH:18][CH:17]=1.[NH:27]1[C:31]2[CH:32]=[CH:33][C:34]([CH:36]=O)=[CH:35][C:30]=2[N:29]=[CH:28]1>>[NH:27]1[C:31]2[CH:32]=[CH:33][C:34]([CH2:36][NH:1][C:4]3[C:5]4[CH:6]=[CH:7][C:8]([NH:15][C:16]5[C:24]6[O:23][C:22]([CH3:26])([CH3:25])[CH2:21][C:20]=6[CH:19]=[CH:18][CH:17]=5)=[N:9][C:10]=4[CH:11]=[CH:12][CH:13]=3)=[CH:35][C:30]=2[N:29]=[CH:28]1참가 물질
4
실험 절차
The title compound, MS: m/e=436.1 (M+H+), was prepared from 5-nitro-2-chloroquinoline, 7-amino-2,3-dihydro-2,2-dimethylbenzofuran (CAS 68298-46-4) and 1H-benzimidazole-5-carbaldehyde as described in example 26.
출처 및 근거
- ORD 기록
- ord-700eea6771684f7d829992aaa5313c1e
- 출처 데이터셋
- uspto-grants-2010_11
- 특허 번호
- US07825253B2
연결된 노트
불러오는 중…